NASDAQ: CYCC
Cyclacel Pharmaceuticals Inc Stock Ownership - Who owns Cyclacel Pharmaceuticals?

Insider buying vs selling

Have Cyclacel Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David E. LazarInterim CEO2025-02-26194,628,820$0.03
$5.45MSell

1 of 1

CYCC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CYCC insiders and whales buy or sell their stock.

CYCC Shareholders

What type of owners hold Cyclacel Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Wong Sing Ee Doris873.86%194,628,820$45.93MInsider
Austin W. Greenhouse David M. Marxe12.60%2,806,900$662.43kInsider
Stanley Morgan10.22%2,276,852$537.34kInsider
James E. Flynn6.22%1,385,091$326.88kInsider
Armistice Capital LLC5.70%1,269,485$299.60kInstitution
Kevin C. Tang1.91%425,700$100.47kInsider
Sukses Engineering Sdn Bhd Suria1.12%250,000$59.00kInsider
Kok Hui Tan1.12%250,000$59.00kInsider
Jien Shiung Ho1.12%250,000$59.00kInsider
Kee Wee Ho1.12%250,000$59.00kInsider

1 of 3

CYCC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CYCC0.79%99.21%Net Selling
MBIO2.60%16.34%Net SellingNet Selling
QLGN0.05%99.95%
APM1.68%37.21%
INTS14.07%11.36%Net BuyingNet Buying

Cyclacel Pharmaceuticals Stock Ownership FAQ

Who owns Cyclacel Pharmaceuticals?

Cyclacel Pharmaceuticals (NASDAQ: CYCC) is owned by 7.30% institutional shareholders, 912.15% Cyclacel Pharmaceuticals insiders, and 0.00% retail investors. Wong Sing Ee Doris is the largest individual Cyclacel Pharmaceuticals shareholder, owning 194.63M shares representing 873.86% of the company. Wong Sing Ee Doris's Cyclacel Pharmaceuticals shares are currently valued at $45.93M.

If you're new to stock investing, here's how to buy Cyclacel Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.